Form 4: Charles River Laboratories Executive Reports Stock Transaction
SEC Form 4 Filing
Joseph W. LaPlume, EVP at Charles River Laboratories, reports disposition of shares to cover tax obligations.
Summary
- On May 29, 2024, Joseph W. LaPlume, an Executive Vice President at Charles River Laboratories, reported a transaction involving the disposition of 223 shares of common stock.
- The shares were disposed of at a price of $214.51 per share.
- Following the transaction, LaPlume directly owns 22,501 shares of Charles River Laboratories common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive stock transactions, common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of stock transaction |
| 05/31/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.